Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Colgate-Palmolive Acquires Tom’s Of Maine In $100 Mil. Deal

This article was originally published in The Tan Sheet

Executive Summary

Colgate-Palmolive's planned acquisition of natural toothpaste marketer Tom's of Maine will establish the company as the only global oral care firm that serves the health and specialty trade channel, Colgate announced March 21

You may also be interested in...

Colgate Says Hello To Subscription-Delivery Wtih Oral Care Line Acquisition

Colgate agrees to purchase Hello Products direct-to-consumer oral care brand, complementing  its Colgate brand and its Tom’s of Maine natural-positioned line. The firm will pay with a combination of cash and debt in the deal expected to close no later than the end of February.

Tom's Of Maine Appealing NAD-Advised Name Change For Naturally Dry Antiperspirant

Tom's of Maine's Naturally Dry Antiperspirant represents a misleading natural claim given that the product’s active wetness-control ingredient is an extensively processed aluminum salt, NAD says, siding with challenger Unilever. Colgate will appeal the decision, arguing that the claims at issue are subject to a 2015 court order and therefore the dispute falls outside of NAD’s jurisdiction.

Tom's Of Maine Ingredients' Efficacy Weighed Against 'Natural' Claim In NAD Review

Tom's of Maine's Naturally Dry Antiperspirant complies with FDA requirement that antiperspirants contain an aluminum salt-based active ingredient, but NAD says “naturally dry” misleads by implying that natural ingredients are responsible for product’s effectiveness. Brand owner Colgate also says an earlier class action settlement of "identical" ad claims precludes a NAD review.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts